Stockysis Logo
  • Login
  • Register
Back to News

Pediatrix Reaffirms FY2026 Adjusted EBITDA Outlook Of $280M-$300M

Benzinga Newsdesk www.benzinga.com Neutral 85.9%
Neg 0% Neu 85.9% Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Terms of Service Contact Us